Skip to main content

Cardiovascular Institute of the South is First in Baton Rouge to Use Right and Left Impella Technology

Press Release

Cardiovascular Institute of the South is First in Baton Rouge to Use Right and Left Impella Technology


BATON ROUGE—September 17, 2020—Dr. Niksad Abraham, interventional cardiologist at Cardiovascular Institute of the South (CIS), is the first in Baton Rouge to conduct a left- and right-sided heart procedure using Impella CP® and Impella RP®, the world’s smallest heart pump. This minimally-invasive and life-saving procedure took place on September 17 at Baton Rouge General Medical Center.

The Impella devices are designed to provide minimally-invasive, temporary support for patients with heart failure during a high-risk coronary intervention. Impella is placed into the heart through a peripheral artery and supports the heart’s circulatory system during the procedure. This device works for the heart, allowing it to rest and recover while doctors place stents in the patient’s arteries to unblock them and increase blood flow. It is also approved to treat cardiogenic shock, when the heart fails to pump enough blood to vital organs, typically during or after a heart attack.

“This technology provides a new treatment option for patients with advanced coronary disease who may have been turned down for heart surgery or whose hearts are too weak to pump on their own after a heart attack,” explained Dr. Abraham. “It allows a patient’s heart to rest and recover during the procedure, ultimately leading to better outcomes and improved quality of life.”

To learn more about Impella or CIS, visit

About Cardiovascular Institute of the South
Founded by Dr. Craig Walker in 1983, Cardiovascular Institute of the South (CIS) is a world-leader in preventing, detecting and treating cardiovascular and peripheral vascular disease. CIS offers a comprehensive heart and vascular program with expert physicians trained in many specialties, including internal medicine, nuclear cardiology, electrophysiology, lipid management, coronary artery disease, peripheral vascular disease, valve disease and interventional cardiovascular procedures. CIS has earned international acclaim as a pioneer of research, development and education, as well as an innovator in the treatment of peripheral vascular disease. With a dedicated team of more than 850 team members, CIS provides comprehensive cardiovascular care at 20 locations across Louisiana and Mississippi, with nine telemedicine programs. CIS remains at the forefront of technology, providing the highest-quality, compassionate care. This mission has guided the institute for more than 37 years of excellence. For more information about CIS, call 1-800-425-2565 or visit

Back to Top